Anhydroicaritin 3-rhamnosyl-(1->2)-rhamnoside

3-[(2S,3S,5R)-4,5-dihydroxy-6-methyl-3-[(2S,3S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one

TVBJKPLTBPGHDJ-BJHUNLLKSA-N CHEBI:197021 0 Reactome links 1 studies

Metabolite details

Identifier: TVBJKPLTBPGHDJ-BJHUNLLKSA-N
InChI Key: TVBJKPLTBPGHDJ-BJHUNLLKSA-N
IUPAC name: 3-[(2S,3S,5R)-4,5-dihydroxy-6-methyl-3-[(2S,3S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one
Preferred name: Anhydroicaritin 3-rhamnosyl-(1->2)-rhamnoside
INN name: —
Synonym: —
ChEBI: CHEBI:197021

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release

Observed in differential profiles

Control_16.6_months_vs_Treatment_16.6_months